Zanidatamab news

All news on Zanidatamab (also known as ZIIHERA): plants, production capacities, investments and involved companies.

12 January 2026

Boehringer Ingelheim and Jazz Pharmaceuticals Collaborate on HER2-Targeted Breast Cancer Therapy

Phase 1b study to test zongertinib and zanidatamab combo in HER2-positive breast cancer, aiming to improve outcomes with dual HER2-targeted therapy.

Who will be producing Zanidatamab in the future?

Find out with chemXplore Alpha

Learn more